I-Mab Biopharma
I-Mab is a dynamic, global biotech company exclusively focused on discovery, development and soon commercialization of novel or highly differentiated biologics in the therapeutic areas of immuno-oncology and autoimmune diseases.
Launch date
Employees
Market cap
$82.2m
Enterprise valuation
($121m) (Public information from Sep 2024)
Share price
$1.11 IMAB
Shanghai Shanghai (HQ)
Authorizing premium user...